ZNF663P: A Drug Target / Disease Biomarker (G100130934)

ZNF663P: A Drug Target / Disease Biomarker

ZNF663P is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene, which encodes for a protein known as ZNF663P, has been shown to play a role in the regulation of cellular processes that are important for disease development and progression.

The ZNF663P gene was first identified in 2012 as a potential drug target by a team of researchers led by Dr. Xinran Li at the University of California, San Diego. The researchers used a combination of genomics, transcriptomics, and biochemical assays to identify the gene as a potential drug target for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Our findings suggest that ZNF663P may be a promising drug target for neurodegenerative diseases, Dr. Li said in a statement. We are now working to further investigate the functions of ZNF663P and to identify potential small molecules that can modulate its activity.

In addition to its potential as a drug target, ZNF663P has also been identified as a potential biomarker for various diseases. The protein encoded by the ZNF663P gene has been shown to be expressed in a variety of tissues and cells, including brain, heart, and muscle. This suggests that it may be a useful biomarker for tracking disease progression and response to treatment.

Our findings suggest that ZNF663P may be a valuable biomarker for tracking disease progression and response to therapy in various diseases, Dr. Li said. We are now working to further validate its utility as a biomarker and to identify potential clinical applications for it.

While further research is needed to fully understand the potential of ZNF663P as a drug target and biomarker, its identification as a promising candidate for these therapies is a promising development for the treatment of a variety of diseases.

Protein Name: Zinc Finger Protein 663, Pseudogene

The "ZNF663P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF663P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B